Filing Details
- Accession Number:
- 0001209191-19-044974
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-07 16:53:21
- Reporting Period:
- 2019-08-05
- Accepted Time:
- 2019-08-07 16:53:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131324 | Genomic Health Inc | GHDX | Services-Medical Laboratories (8071) | 770552594 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1337334 | Steven Shak | 301 Penobscot Drive Redwood City CA 94063 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-08-05 | 22,529 | $71.22 | 111,266 | No | 4 | S | Indirect | Held by the Shak Family Trust |
| Common Stock | Disposition | 2019-08-05 | 2,471 | $71.85 | 108,795 | No | 4 | S | Indirect | Held by the Shak Family Trust |
| Common Stock | Disposition | 2019-08-06 | 16,860 | $72.14 | 91,935 | No | 4 | S | Indirect | Held by the Shak Family Trust |
| Common Stock | Disposition | 2019-08-06 | 8,140 | $72.86 | 83,795 | No | 4 | S | Indirect | Held by the Shak Family Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Held by the Shak Family Trust |
| No | 4 | S | Indirect | Held by the Shak Family Trust |
| No | 4 | S | Indirect | Held by the Shak Family Trust |
| No | 4 | S | Indirect | Held by the Shak Family Trust |
Footnotes
- These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on June 3, 2019.
- Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- Represents weighted average sale price. Actual sale prices ranged from $70.72 to $71.71.
- Includes an aggregate of 9,210 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Represents weighted average sale price. Actual sale prices ranged from $71.73 to $72.14.
- Represents weighted average sale price. Actual sale prices ranged from $71.61 to $72.59.
- Represents weighted average sale price. Actual sale prices ranged from $72.61 to $73.14.
Billionaire Hedge Funds
